stars 1 stars 2 stars 3

A leading Biopharmaceutical company in China engaging in R&D, manufacturing and marketing of gene engineering and biochemical drugs including: Filgrastim, Oprelvekin (Interleukin-11), Enoxaparin sodium, Palonosetron and BMP-2 (Recombinant Human Bone Morphogenetic Protein-2). Drug pipeline mainly includes Liraglutide, Fulvestrant, Fosaprepitant, pegfilgrastim, long lasting EPO and other high value biosimilars and long lasting formulations.

View Top Employees from Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Website http://www.china-gene.com
Revenue $5.2 million
Employees 21 (21 on RocketReach)
Founded 1993
Phone +86 571 8687 9123
Technologies
Industry Pharmaceutical Manufacturing, Manufacturing General, Manufacturing
Web Rank 17 Million
Keywords 岗位设置论证意见
SIC SIC Code 28 Companies, SIC Code 283 Companies
NAICS NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies

Hangzhou Jiuyuan Gene Engineering Co., Ltd. Questions

The Hangzhou Jiuyuan Gene Engineering Co., Ltd. annual revenue was $5.2 million in 2024.

Li Zhou is the Director, Overseas Marketing of Hangzhou Jiuyuan Gene Engineering Co., Ltd..

21 people are employed at Hangzhou Jiuyuan Gene Engineering Co., Ltd..

The NAICS codes for Hangzhou Jiuyuan Gene Engineering Co., Ltd. are [32541, 32, 325, 3254].

The SIC codes for Hangzhou Jiuyuan Gene Engineering Co., Ltd. are [28, 283].

Top Hangzhou Jiuyuan Gene Engineering Co., Ltd. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users